Search
CELL BANK Website

Back Back
Cell No. : Cell Name
RCB5714 : Y-MESO-61   update : 2025/01/22
Comment
Comment from the depositorHuman pleural mesothelioma cell line. Epithelioid type.
Terms and conditionsIn publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature (Cancer Sci 2015 106(8):990-9) designated by the DEPOSITOR is requested.
Remarks
Order Form Order Form(C-0005.pdf)   MTA(C-0007.pdf)   MTA(C-0007p.pdf)  
Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp).
Basic information IPR Aichi Cancer Center (Japan)
Depositor SEKIDO, Yoshitaka
Originator SEKIDO, Yoshitaka
Year of deposit 2022
Cloning (depositor) No
Animal _human < Mammals
Genus Homo
Species sapiens
Race Japanese
Gender Male
Age at sampling 65 years
Tissue pleural effusion
Primary focus pleural mesothelioma
Disease name pleural mesothelioma
Tumor pleural mesothelioma (pT2N2M0, Stage IIIB)
Metastatic ability Unknown
Classification cancer
Recombinant non-recombinant
Year of origin 2011
Lifespan infinite
deposit info
lot info
Medium Medium List
Culture type Adherent cells Adherent cells
Culture medium RPMI1640 + 10% FBS RPMI1640 + 10% FBS
Antibiotics 1% antimicrobial Free
Passage method 0.25w/v% Trypsin + 1mmol/l EDTA (FUJIFILM 209-16941) 0.25% Trypsin + (0.02% EDTA or 0.04% EDTA)
Culture information Passage ratio 1 : 5-8 split 1 : 5 split
SC frequency Subculture : 1-2 times/week Subculture : 1-2 times/week
Temperature 37 ℃ 37 ℃
CO2 concentration 5 % 5 %
Freeze medium CELLBANKER CELLBANKER 1
Freezing method Slow freezing
Mycoplasma/Acholeplasma (-)
Mycoplasma (-)
Animal PCR OK
Virus (HIV) (-)
Virus (HBV) (-)
Virus (HCV) (-)
Virus OK
deposit info
D5S818 D13S317 D7S820 D16S539 vWA TH01 Amelogenin TPOX CSF1PO
10,11 11 11,13 10,11 17,19 7,8 X,Y 9,11 10,12
lot info
D5S818 D13S317 D7S820 D16S539 vWA TH01 Amelogenin TPOX CSF1PO
10,11 11 11,13 10,11 17,19 7,8 X,Y 9,11 10,12
Reference information Reference 2
User's Publication 0


To topTop
Reference
16027  Matsushita A, Sato T, Mukai S, Fujishita T, Mishiro-Sato E, Okuda M, Aoki M, Hasegawa Y, Sekido Y.  TAZ activation by Hippo pathway dysregulation induces cytokine gene expression and promotes mesothelial cell transformation  Oncogene  2018  38(11):1966-1978  PubMed ID: 30401981   DOI: 10.1038/s41388-018-0417-7
16468  Hakiri S, Osada H, Ishiguro F, Murakami H, Murakami-Tonami Y, Yokoi K, Sekido Y.  Functional differences between wild-type and mutant-type BRCA1-associated protein 1 tumor suppressor against malignant mesothelioma cells  Cancer Sci  2015  106(8):990-9.  PubMed ID: 26011428   DOI: 10.1111/cas.12698

To topTop
User's Publication



Back Back Return Top Page